$1,000 invested AbbVie Inc. (2016)
NYSE · ABBV · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-10-15
Today you would have
$7,578
+$6,578 (+657.81%)
ABBVSPY (benchmark)
- Entry price
- $37.40
- Current price
- $283.40
- Shares
- 26.7399
- CAGR
- +20.67%
- Max Drawdown
- -45.09%
- vs SPY
- +303.57 pp
✦The story
A $1,000 position in AbbVie opened in January 2016 was worth $7,578 by July 2026, a total return of +657.8% versus +354.2% for the S&P 500. Over that decade AbbVie rode the peak years of Humira, one of the world's best-selling drugs, and built out its immunology and aesthetics portfolio, including the Allergan acquisition. The ride included a maximum drawdown of 45.1%.
#Related scenariosfor comparison
Other years for ABBV